CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Ordinary Shares	Additional Paid-In Capital	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit	Total
Balances at Dec. 31, 2022	$ 1	$ 1,295,725	$ (15)	$ (853,911)	$ 441,800
Balances (in shares) at Dec. 31, 2022	65,227
Increase (Decrease) in Stockholders' Equity
Repurchase of ordinary shares, net of transaction costs		(135,896)			(135,896)
Repurchase of ordinary shares, net of transaction costs (in shares)	(12,441)
Proceeds from ESPP purchases		446			446
Proceeds from ESPP purchases (in shares)	63
Employee share-based compensation expense		13,285			13,285
Issuance of restricted shares (in shares)	981
Repurchase of shares to satisfy tax withholding		(1,470)			(1,470)
Repurchase of shares to satisfy tax withholding (in shares)	(136)
Net unrealized gain on marketable securities			(271)		(271)
Net Income (Loss)				(37,733)	(37,733)
Balances at Jun. 30, 2023	$ 1	1,172,090	(286)	(891,644)	280,161
Balances (in shares) at Jun. 30, 2023	53,694
Balances at Mar. 31, 2023	$ 1	1,246,506	51	(875,999)	370,559
Balances (in shares) at Mar. 31, 2023	60,542
Increase (Decrease) in Stockholders' Equity
Repurchase of ordinary shares, net of transaction costs		(80,543)			(80,543)
Repurchase of ordinary shares, net of transaction costs (in shares)	(7,283)
Proceeds from ESPP purchases		446			446
Proceeds from ESPP purchases (in shares)	63
Employee share-based compensation expense		6,264			6,264
Issuance of restricted shares (in shares)	424
Repurchase of shares to satisfy tax withholding		(583)			(583)
Repurchase of shares to satisfy tax withholding (in shares)	(52)
Net unrealized gain on marketable securities			(337)		(337)
Net Income (Loss)				(15,645)	(15,645)
Balances at Jun. 30, 2023	$ 1	1,172,090	(286)	(891,644)	280,161
Balances (in shares) at Jun. 30, 2023	53,694
Balances at Dec. 31, 2023		1,122,164	(65)	(909,104)	$ 212,995
Balances (in shares) at Dec. 31, 2023	48,091				48,091
Increase (Decrease) in Stockholders' Equity
Proceeds from the sale of ordinary shares		44			$ 44
Proceeds from the sale of ordinary shares (in shares)	5
Repurchase of ordinary shares, net of transaction costs		(445)			(445)
Repurchase of ordinary shares, net of transaction costs (in shares)	(38)
Proceeds from ESPP purchases		375			375
Proceeds from ESPP purchases (in shares)	45
Employee share-based compensation expense		10,604			10,604
Issuance of restricted shares (in shares)	1,013
Repurchase of shares to satisfy tax withholding		(1,734)			(1,734)
Repurchase of shares to satisfy tax withholding (in shares)	(194)
Net unrealized gain on marketable securities			43		43
Net Income (Loss)				(28,193)	(28,193)
Balances at Jun. 30, 2024		1,131,008	(22)	(937,297)	$ 193,689
Balances (in shares) at Jun. 30, 2024	48,922				48,922
Balances at Mar. 31, 2024		1,125,677	(41)	(920,768)	$ 204,868
Balances (in shares) at Mar. 31, 2024	48,566
Increase (Decrease) in Stockholders' Equity
Proceeds from the sale of ordinary shares		44			44
Proceeds from the sale of ordinary shares (in shares)	5
Proceeds from ESPP purchases		375			375
Proceeds from ESPP purchases (in shares)	45
Employee share-based compensation expense		5,376			5,376
Issuance of restricted shares (in shares)	354
Repurchase of shares to satisfy tax withholding		(464)			(464)
Repurchase of shares to satisfy tax withholding (in shares)	(48)
Net unrealized gain on marketable securities			19		19
Net Income (Loss)				(16,529)	(16,529)
Balances at Jun. 30, 2024		$ 1,131,008	$ (22)	$ (937,297)	$ 193,689
Balances (in shares) at Jun. 30, 2024	48,922				48,922